138 related articles for article (PubMed ID: 26828595)
21. Elevated serum YKL-40 level predicts poor prognosis in hepatocellular carcinoma after surgery.
Zhu CB; Chen LL; Tian JJ; Su L; Wang C; Gai ZT; Du WJ; Ma GL
Ann Surg Oncol; 2012 Mar; 19(3):817-25. PubMed ID: 21861215
[TBL] [Abstract][Full Text] [Related]
22. Mass spectrometric identification, characterization and validation of the haptoglobin β-chain protein as a lung cancer serum biomarker.
Ayyub A; Saleem M; Musharraf SG; Naz M; Tariq A; Hashmi N
Mol Med Rep; 2015 Sep; 12(3):3755-3762. PubMed ID: 26005016
[TBL] [Abstract][Full Text] [Related]
23. The prognostic value of YKL-40 concentrations in nonmyeloablative conditioning allogeneic hematopoietic cell transplantation.
Mørup AM; Kornblit B; Johansen JS; Masmas TN; Madsen HO; Vindeløv L; Garred P
Biol Blood Marrow Transplant; 2011 Sep; 17(9):1299-307. PubMed ID: 21232622
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis.
Gu XB; Tian T; Tian XJ; Zhang XJ
Sci Rep; 2015 Jul; 5():12493. PubMed ID: 26205001
[TBL] [Abstract][Full Text] [Related]
25. Observational and genetic plasma YKL-40 and cancer in 96,099 individuals from the general population.
Kjaergaard AD; Nordestgaard BG; Johansen JS; Bojesen SE
Int J Cancer; 2015 Dec; 137(11):2696-704. PubMed ID: 26095694
[TBL] [Abstract][Full Text] [Related]
26. The Prognostic and Clinicopathological Significance of IGF-1R in NSCLC: a Meta-Analysis.
Zhao J; Shi X; Wang T; Ying C; He S; Chen Y
Cell Physiol Biochem; 2017; 43(2):697-704. PubMed ID: 28946136
[TBL] [Abstract][Full Text] [Related]
27. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
28. Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients.
Zhao QT; Yuan Z; Zhang H; Zhang XP; Wang HE; Wang ZK; Duan GC
Int J Cancer; 2016 Jul; 139(1):164-70. PubMed ID: 26915723
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of serum LDH in small cell lung cancer: A systematic review with meta-analysis.
Zhang X; Guo M; Fan J; Lv Z; Huang Q; Han J; Wu F; Hu G; Xu J; Jin Y
Cancer Biomark; 2016; 16(3):415-23. PubMed ID: 27062698
[TBL] [Abstract][Full Text] [Related]
30. Integrated Analysis Reveals That Long Non-Coding RNA TUBA4B Can Be Used as a Prognostic Biomarker in Various Cancers.
Zhang T; Wu DM; Deng SH; Han R; Liu T; Li J; Xu Y
Cell Physiol Biochem; 2018; 49(2):530-544. PubMed ID: 30157490
[TBL] [Abstract][Full Text] [Related]
31. CHI3L1 plays a role in cancer through enhanced production of pro-inflammatory/pro-tumorigenic and angiogenic factors.
Libreros S; Garcia-Areas R; Iragavarapu-Charyulu V
Immunol Res; 2013 Dec; 57(1-3):99-105. PubMed ID: 24222276
[TBL] [Abstract][Full Text] [Related]
32. Elevated levels of preoperative circulating CD44⁺ lymphocytes and neutrophils predict poor survival for non-small cell lung cancer patients.
Yang SZ; Ji WH; Mao WM; Ling ZQ
Clin Chim Acta; 2015 Jan; 439():172-7. PubMed ID: 25451952
[TBL] [Abstract][Full Text] [Related]
33. Elevated serum soluble programmed cell death ligand 1 concentration as a potential marker for poor prognosis in small cell lung cancer patients with chemotherapy.
Jin J; Si J; Liu Y; Wang H; Ni R; Wang J
Respir Res; 2018 Oct; 19(1):197. PubMed ID: 30290817
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: a systematic review and meta-analysis.
Zhang H; Gao L; Zhang B; Zhang L; Wang C
Sci Rep; 2016 Mar; 6():22618. PubMed ID: 26939789
[TBL] [Abstract][Full Text] [Related]
35. Serum miR-499 as a novel diagnostic and prognostic biomarker in non-small cell lung cancer.
Li M; Zhang Q; Wu L; Jia C; Shi F; Li S; Peng A; Zhang G; Song X; Wang C
Oncol Rep; 2014 Apr; 31(4):1961-7. PubMed ID: 24549225
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of the maximum standardized uptake value of pre-treatment primary lesions in small-cell lung cancer on 18F-FDG PET/CT: a meta-analysis.
Zhu D; Wang Y; Wang L; Chen J; Byanju S; Zhang H; Liao M
Acta Radiol; 2018 Sep; 59(9):1082-1090. PubMed ID: 29256260
[TBL] [Abstract][Full Text] [Related]
37. Correlation of chitinase 3-like 1 single nucleotide polymorphisms and haplotypes with uterine cervical cancer in Taiwanese women.
Lin YS; Liu YF; Chou YE; Yang SF; Chien MH; Wu CH; Chou CH; Cheng CW; Wang PH
PLoS One; 2014; 9(9):e104038. PubMed ID: 25203433
[TBL] [Abstract][Full Text] [Related]
38. Role of Chitinase 3-like 1 as a Biomarker in Multiple Sclerosis: A Systematic Review and Meta-analysis.
Floro S; Carandini T; Pietroboni AM; De Riz MA; Scarpini E; Galimberti D
Neurol Neuroimmunol Neuroinflamm; 2022 Jul; 9(4):. PubMed ID: 35534236
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of serum cytokeratin 19 fragments (Cyfra 21-1) in patients with non-small cell lung cancer.
Xu Y; Xu L; Qiu M; Wang J; Zhou Q; Xu L; Wang J; Yin R
Sci Rep; 2015 Apr; 5():9444. PubMed ID: 25901419
[TBL] [Abstract][Full Text] [Related]
40. Serum Cripto-1 is a novel biomarker for non-small cell lung cancer diagnosis and prognosis.
Xu CH; Wang Y; Qian LH; Yu LK; Zhang XW; Wang QB
Clin Respir J; 2017 Nov; 11(6):765-771. PubMed ID: 26605871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
